Shares in Novo Nordisk (NYSE:NVO) rose today after the insulin-maker met expectations on Wall Street with its 1st quarter results.
The Denmark-based company posted profits of $1.49 billion, or 60¢ per share, on sales of $4.18 billion for the 3 months ended March 31, for bottom-line growth of 7% on sales growth of 5% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Nordisk shares climb after Q1 beat appeared first on MassDevice.